ArticleFrontiers in endocrinology2025
Cardiometabolic index predicts cardiovascular events in aging population: a machine learning-based risk prediction framework from a large-scale longitudinal study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Unraveling 'F' factor: towards a genetic-clinical framework for the musculoskeletal-heart crosstalk in metabolic aging.Cardiovascular diabetology · 2026Article
- Associations Between the Modified Cardiometabolic Index and Stroke in Patients With Different Glucose Metabolism Statuses: Evidence From a Nationally Representative Survey.Reviews in cardiovascular medicine · 2026Article
- Modified cardiometabolic index and the risk of new-onset chronic diseases: a nationwide prospective cohort study.Diabetology & metabolic syndrome · 2026Article
- Cardiometabolic Index, BMI, Waist Circumference, and Cardiometabolic Multimorbidity Risk in Older Adults.Geriatrics (Basel, Switzerland) · 2025Article
- Metabolic Syndrome in Older Adults: When Function Trumps Numbers.TouchREVIEWS in endocrinology · 2025Article
- New insights into the association between cardiometabolic index with metabolic profile, nutritional status, and inflammaging in older adults.Frontiers in aging · 2025Article
- Cardiometabolic index as a predictor of major adverse cardiovascular events in atrial fibrillation: insights from a community-based cohort.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While the Cardiometabolic Index (CMI) serves as a novel marker for assessing adipose tissue distribution and metabolic function, its prognostic utility for cardiovascular disease (CVD) events remains incompletely understood. This investigation sought to elucidate the predictive capabilities of CMI for cardiovascular outcomes and explore underlying mechanistic pathways to establish a comprehensive risk prediction framework. Methods: The study encompassed 7,822 individuals from a national health and retirement longitudinal cohort, with participants stratified by CMI quartiles. Following baseline characteristic comparisons and CVD incidence rate calculations, we implemented multiple Cox regression models to assess CMI's cardiovascular risk prediction capabilities. For nomogram construction, we utilized an ensemble machine learning framework, combining Boruta algorithm-based feature selection with Random Forest (RF) and XGBoost analyses to determine key predictive parameters. Results: Throughout the median follow-up duration of 84 months, we documented 1,500 incident CVD cases, comprising 1,148 cardiac events and 488 cerebrovascular events. CVD incidence demonstrated a positive gradient across ascending CMI quartiles. Multivariate Cox regression analysis, adjusting for potential confounders, confirmed a significant association between CMI and CVD risk. Notably, mediation analyses revealed that hypertension and glycated hemoglobin (HbA1c) potentially serve as mechanistic intermediaries in the CMI-CVD relationship. Sex-stratified analyses suggested differential predictive patterns between gender subgroups. Given CMI's robust and consistent predictive capability for stroke outcomes, we developed a machine learning-derived nomogram incorporating five key predictors: age, CMI, hypertension status, high-sensitivity C-reactive protein (hsCRP) and renal function (measured as serum creatinine). The nomogram demonstrated strong discriminative ability, achieving areas under the receiver operating characteristic curve (AUC) of 0.76 (95% CI: 0.56-0.97) and 0.74 (95% CI: 0.66-0.81) for 2-year and 6-year stroke prediction, respectively. Conclusions: Our findings establish CMI as a significant predictor of cardiovascular events in the aging population, with the relationship partially mediated through hypertension and insulin resistance pathways. The validated nomogram, developed using longitudinal data from a substantial elderly cohort, incorporates CMI to enable preclinical risk stratification, supporting timely preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.